Yüklüyor......
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
BACKGROUND: We have harnessed a novel biological system, the bacterial minicell, to deliver cancer therapeutics to cancer cells. Preclinical studies showed that epidermal growth factor receptor (EGFR)-targeted, paclitaxel-loaded minicells ((EGFR)minicells(Pac)) have antitumor effects in xenograft mo...
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699457/ https://ncbi.nlm.nih.gov/pubmed/26659127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144559 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|